The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis

Annals of the Rheumatic Diseases

Volumn 75, Issue 5, 2016, Pages 791-794

  Deodhar, Atul ^a   Strand, Vibeke ^b   Kay, Jonathan ^c   Braun, Juergen ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AXIAL SPONDYLOARTHRITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG APPROVAL; HUMAN; IMAGE ANALYSIS; LOW ENERGY RADIATION; MUSCULOSKELETAL DISEASE ASSESSMENT; NON RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS; PATIENT CODING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SACROILIITIS; SPINE RADIOGRAPHY; SPONDYLARTHRITIS; ANTAGONISTS AND INHIBITORS; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; NOMENCLATURE; RADIOGRAPHY; SPONDYLITIS, ANKYLOSING;

ANTIRHEUMATIC AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING; TERMINOLOGY AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84956644032     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-208852     Document Type: Article

References (45)

1. Reveille JD, Witter JP, Weisman MH. Prevalence of axial spondyloarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res (Hoboken) 2012;64:905-10.
2. Rudwaleit M, Landewé R, van der Heijde D, et al. The Development of Assessment of SpondyloArthritis international Society (ASAS) Classification Criteria for Axial Spondyloarthritis (Part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770-6.
3. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
4. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
5. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991;34:1218-27.
6. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab-a double-blind placebo controlled multicenter trial. Lancet 2002;359:1187-93.
7. Braun J, Deodhar A, Inman RD, et al. Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis:104-week results of the GO-RAISE study. Ann Rheum Dis 2012;71:661-7.
8. Landewé R, Braun J, Deodhar A, et al. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis:24-week results of a double-blind randomised placebo-controlled Phase 3 study. Ann Rheum Dis 2014;73:39-47.
9. Barkham N, Keen HI, Coates LC, et al. Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009;60:946-54.
10. Sieper J, van der Heijde D, Dougados M, et al. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis 2013;72:815-22.
11. Dougados M, van der Heijde D, Sieper J, et al. Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol 2014;66:2091-102.
12. Sieper J, van der Heijde D, Dougados M, et al. A randomized, double-blind, placebo-controlled, 16-week study of subcutaneous golimumab in patients with active non-radiographic axial spondyloarthritis. Arthritis Rheumatol 2015;67:2702-12.
13. Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994;37:1039-45.
14. Sieper J, van der Heijde D. Review: Nonradiographic axial spondyloarthritis: new definition of an old disease? Arthritis Rheum 2013;65:543-51.
15. Khan MA, van der Linden SM, Kushner I, et al. Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum 1985;28:40-3.
16. Braun J, Baraliakos X. Imaging of axial spondyloarthritis including ankylosing spondylitis. Ann Rheum Dis 2011;70(Suppl 1):i97-103.
17. Vogler JB III, Brown WH, Helms CA, et al. The normal sacroiliac joint: a CT study of asymptomatic patients. Radiology 1984;151:433-7.
18. Yang CH, Wu TH, Chiou YY, et al. Imaging quality and diagnostic reliability of low-dose computed tomography lumbar spine for evaluating patients with spinal disorders. Spine J 2014;14:2682-90.
19. van Tubergen A, Heuft-Dorenbosch L, Schulpen G, et al. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality? Ann Rheum Dis 2003;62:519-25.
20. van den Berg R, Lenczner G, Thévenin F, et al. Classification of axial SpA based on positive imaging (radiographs and/or MRI of the sacroiliac joints) by local rheumatologists or radiologists versus central trained readers in the DESIR cohort. Ann Rheum Dis 2015;74:2016-21.
21. van den Berg R, Lenczner G, Feydy A, et al. Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs. Results from the DESIR cohort. Arthritis Rheumatol 2014;66:2403-11.
22. van der Heijde D, Sieper J, Maksymowych WP, et al. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis. Arthritis Rheumatol 2014;66:667-730.
23. Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009;68:1520-7.
24. Hermann KG, Baraliakos X, van der Heijde D, et al. Assessment in SpondyloArthritis international Society (ASAS). Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Ann Rheum Dis 2012;71:1278-88.
25. Kjaer P, Korsholm L, Bendix T, et al. Modic changes and their associations with clinical findings. Eur Spine J 2006;15:1312-19.
26. Modic MT, Steinberg PM, Ross JS, et al. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology 1988;166(1 Pt 1):193-9.
27. Deodhar A, Reveille JD, van den Bosch F, et al. The concept of axial spondyloarthritis: Joint statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns. Arthritis Rheumatol 2014;66:2649-56.
28. Sampaio-Barros PD, Bortoluzzo AB, Conde RA, et al. Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol 2010;37:1195-9.
29. Mau W, Zeidler H, Mau R, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year follow up. J Rheumatol 1988;15:1109-14.
30. Ruderman E, Strand V, Joshi A, et al. Spondyloarthritis Epidemiology and Burden Phase 2 [SPEED 2] Study: disease progression in axial spondyloarthropathy (SpA) [Abstract]. Arthritis Rheum 2013;65(10 Suppl):S1052-3.
31. Dougados M, Demattei C, van den Berg R, et al. Genetic (HLA B27), environmental (smoking) and inflammatory (MRI positivity) factors are independent predictors of radiographic progression of the sacroiliac joints in early axial non-radiographic spondyloarthritis [Abstract]. Ann Rheum Dis 2015;74(Suppl 2):757.
32. Poddubnyy D, Haibel H, Braun J, et al. Clinical course over two years in patients with early non-radiographic axial spondyloarthritis and ankylosing spondylitis without anti-tumor necrosis factor α treatment: results from the GErman SPondyloarthritis Inception Cohort (GESPIC). Arthritis Rheumatol 2015;67:2369-75.
33. Kiltz U, Baraliakos X, Karakostas P, et al. Do patients with non-radiographic axial spondyloarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res (Hoboken) 2012;64:1415-22.
34. Ramiro S, Stolwijk C, van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis 2015;74:52-9.
35. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
36. Klingberg E, Lorentzon M, Gothlin J, et al. Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes. Arthritis Res Ther 2013;15:R179.
37. Vosse D, Landewe R, van der Heijde D, et al. Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study. Ann Rheum Dis 2009;68:1839-18042.
38. Aggarwal R, Ringold S, Khanna D, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res 2015;67:891-7.
39. Braun J, Inman R. Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis. Ann Rheum Dis 2010;69:1264-8.
40. Braun J, Baraliakos X, Kiltz U, et al. Classification and diagnosis of axial spondyloarthritis.what is the clinically relevant difference? J Rheum 2015;42:31-8.
41. Heuft-Dorenbosch L, Landewe R, Weijers R, et al. Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back pain. Ann Rheum Dis 2006;65:804-8.
42. Strand V, Rao SA, Shillington AC, et al. Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res (Hoboken) 2013;65:1299-306.
43. Deodhar A, Mease PJ, Reveille JD, et al. Prevalence of axial spondyloarthritis among undiagnosed chronic back pain patients in the United States [Abstract]. Ann Rheum Dis 2014;73(Suppl 2):198-9.
44. van der Heijde D, Sieper J, Maksymowych WP, et al. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 2011;70:905-8.
45. Boonen A, Sieper J, van der Heijde D, et al. The burden of non-radiographic axial spondyloarthritis. Semin Arthritis Rheum 2015;44:556-62.